Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
Singtel faces a rapidly changing environment as geopolitics, customer expectations and AI reshape its business. In discussion with Criticaleye Senior Editor Bridgette Hall, Group Chief People & Sustainability Office...
After four years in the Group CFO role at one of Singapore’s most prominent real estate developers, GuocoLand Group, Andrew Chew talks to Jacob Ambrose Willson about stepping up from regional CFO to Group, managin...
After a whirlwind journey from the NYSE to private ownership, PropertyGuru CFO Joe Dische reflects on making the hard calls. In this interview with Criticaleye Senior Editor Bridgette Hall, he discusses public vs privat...
Displaying 1 to 3 of 411
 (002).png "Palo Alto Networks"){kind=logo}
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
